SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up
13 references·0 citing·39 second hop
Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up (2020)Health Care Costs Associated With Macrova…Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany (2018)Health Care Costs Associated …Future Directions for Cost-effectiveness Analyses in Health and Medicine (2018)Future Directions for Cost-ef…Economic Costs of Diabetes in the U.S. in 2017 (2018)Economic Costs of Diabetes in…Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Recommendations for Conduct, …The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84) (2014)The impact of diabetes‐relate…Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012) (2014)Direct medical costs of compl…Hospital ownership and performance: Evidence from stroke and cardiac treatment in Taiwan (2008)Hospital ownership and perfor…Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain (2005)Review of the cost of diabete…The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) (2003)The impact of diabetes‐relate…Taiwan’s New National Health Insurance Program: Genesis And Experience So Far (2003)Taiwan’s New National Health …Economic Costs of Diabetes in the U.S. in 2002 (2003)Economic Costs of Diabetes in…Direct medical costs for patients with type 2 diabetes in Sweden (2000)Direct medical costs for pati…Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. (1999)Type 2 diabetes: incremental …Modelling EuroQol health‐related utility values for diabetic complications from CODE‐2 data (2004)The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making (2004)Estimating the Cost of Complications of Diabetes in Australia Using Administrative Health-Care Data (2007)Cost-effectiveness of insulin analogues for diabetes mellitus (2009)The costs of treating long-term diabetic complications in a developing country: a study from India. (2013)A Comparison of Alternative Models for the Demand for Medical Care (1983)Societal costs of diabetes mellitus in Denmark (2015)Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial (2018)Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S. (1998)A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) (2004)Economic Costs of Diabetes in the U.S. in 2012 (2013)Cost-of-Illness Methodology: A Guide to Current Practices and Procedures (1982)Health care expenditures for people with diabetes mellitus, 1992. (1994)Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Resource use and costs in a Swedish cohort of patients with Parkinson's disease (2002)Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective (2007)Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates (2010)Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) (2000)Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis (2010)Diabetes expenditure, burden of disease and management in 5 EU countries (2012)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Understanding Costs of Care in the Operating Room (2018)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Review of statistical methods for analysing healthcare resources and costs (2010)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses (2020)Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden (2020)Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease (2022)A 10-Year Experience with Universal Health Insurance in Taiwan: Measuring Changes in Health and Health Disparity (2008)Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage (2008)Consolidating the social health insurance schemes in China: towards an equitable and efficient health system (2015)Social Determinants of Health and Diabetes: A Scientific Review (2020)Economic Costs of Diabetes in the U.S. in 2022 (2023)The Economic Burden of Racial, Ethnic, and Educational Health Inequities in the US (2023)The State of US Health, 1990-2010 (2013)
this work references cited by second hop

References

  • 2003Economic Costs of Diabetes in the U.S. in 20024,147 cited
  • 2016Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses3,063 cited
  • 2018Economic Costs of Diabetes in the U.S. in 20172,528 cited
  • 2003Taiwan’s New National Health Insurance Program: Genesis And Experience So Far696 cited
  • 2003The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)246 cited
  • 2014The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84)192 cited
  • 2000Direct medical costs for patients with type 2 diabetes in Sweden153 cited
  • 2018Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany141 cited
  • 2014Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012)130 cited
  • 2005Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain128 cited
  • 1999Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.124 cited
  • 2008Hospital ownership and performance: Evidence from stroke and cardiac treatment in Taiwan106 cited
  • 2018Future Directions for Cost-effectiveness Analyses in Health and Medicine94 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cited by

No citing works inside the corpus for this window.